James Corbett - Dec 12, 2022 Form 4 Insider Report for AVITA Medical, Inc. (RCEL)

Role
CEO, Director
Signature
/s/ Donna Shiroma, by power of attorney
Stock symbol
RCEL
Transactions as of
Dec 12, 2022
Transactions value $
$0
Form type
4
Date filed
12/14/2022, 04:23 PM
Previous filing
Dec 27, 2021
Next filing
Jun 8, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCEL Stock Options (Right to Buy) Award $0 +226K $0.00 226K Dec 12, 2022 Common Stock 226K $5.64 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These Stock Options were previously granted pursuant to the Reporting Person's Employment Agreement, dated September 26, 2022 and effective September 28, 2022, subject to stockholder approval. On December 12, 2022, the Issuer's stockholders approved the grant of the Stock Options at the Issuer's annual meeting.
F2 These Stock Options vest in four equal annual installments beginning on September 28, 2023.